Mahendra Deonorain

Mahendra Deonorain

Company: Antikor Biopharma

Job title: Chief Executive Officer, Chief Science & Operating Officer


Delving into Antibody Fragment Drug Conjugates (FDCs): Building a Platform to Harness the Power of Penetration 12:00 pm

Why haven’t antibody fragments such as scFvs and Fab made good drug conjugate products, until now? Designing and using antibody libraries specifically for bio-conjugation Examples of FDC products that can compete and out-perform conventional ADC in preclinical models of cancerRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.